These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
256 related articles for article (PubMed ID: 21934531)
21. Candesartan cilexetil: a new, long-acting, effective angiotensin II type 1 receptor blocker. Sever P J Hum Hypertens; 1997 Sep; 11 Suppl 2():S91-5. PubMed ID: 9331018 [TBL] [Abstract][Full Text] [Related]
22. Protective effect of candesartan in experimental ischemic stroke in the rat mediated by AT2 and AT4 receptors. Faure S; Bureau A; Oudart N; Javellaud J; Fournier A; Achard JM J Hypertens; 2008 Oct; 26(10):2008-15. PubMed ID: 18806625 [TBL] [Abstract][Full Text] [Related]
23. Neuroprotective effects of angiotensin II type 1 receptor (AT1-R) blocker via modulating AT1-R signaling and decreased extracellular glutamate levels. Fujita T; Hirooka K; Nakamura T; Itano T; Nishiyama A; Nagai Y; Shiraga F Invest Ophthalmol Vis Sci; 2012 Jun; 53(7):4099-110. PubMed ID: 22661470 [TBL] [Abstract][Full Text] [Related]
24. Effects of candesartan cilexetil (TCV-116) and enalapril in 5/6 nephrectomized rats. Noda M; Fukuda R; Matsuo T; Ohta M; Nagano H; Imura Y; Nishikawa K; Shibouta Y Kidney Int Suppl; 1997 Dec; 63():S136-9. PubMed ID: 9407442 [TBL] [Abstract][Full Text] [Related]
25. Long-term angiotensin II AT1 receptor inhibition produces adipose tissue hypotrophy accompanied by increased expression of adiponectin and PPARgamma. Zorad S; Dou JT; Benicky J; Hutanu D; Tybitanclova K; Zhou J; Saavedra JM Eur J Pharmacol; 2006 Dec; 552(1-3):112-22. PubMed ID: 17064684 [TBL] [Abstract][Full Text] [Related]
26. Cooperative effect of angiotensin AT(1) and endothelin ET(A) receptor antagonism limits the brain damage after ischemic stroke in rat. Stenman E; Jamali R; Henriksson M; Maddahi A; Edvinsson L Eur J Pharmacol; 2007 Sep; 570(1-3):142-8. PubMed ID: 17597600 [TBL] [Abstract][Full Text] [Related]
27. Additive renoprotective effect of candesartan and tetrahydrobiopterin in rats after 5/6 nephrectomy. Podjarny E; Bernheim J; Hasdan G; Karsh D; Rashid G; Green J; Katz B; Bernheim J Nephrol Dial Transplant; 2007 Jul; 22(7):1864-72. PubMed ID: 17442743 [TBL] [Abstract][Full Text] [Related]
28. Comparison between single and combined treatment with candesartan and pioglitazone following transient focal ischemia in rat brain. Schmerbach K; Schefe JH; Krikov M; Müller S; Villringer A; Kintscher U; Unger T; Thoene-Reineke C Brain Res; 2008 May; 1208():225-33. PubMed ID: 18378216 [TBL] [Abstract][Full Text] [Related]
29. Pharmacokinetic-pharmacodynamic interactions of candesartan cilexetil and losartan. Azizi M; Chatellier G; Guyene TT; Ménard J J Hypertens; 1999 Apr; 17(4):561-8. PubMed ID: 10404959 [TBL] [Abstract][Full Text] [Related]
30. [Change from ACE inhibitor, Ca-antagonist or beta-blocker to candesartan cilexetil: better efficacy and tolerance. SWITCH study (German study segment)]. Baumgart P; Reismann J; Pohlmeyer H; Düsing R Dtsch Med Wochenschr; 2001 May; 126(19):547-50. PubMed ID: 11402910 [TBL] [Abstract][Full Text] [Related]
31. Effects of the angiotensin AT1 receptor blocker candesartan on myocardial ischemic/reperfusion injury. Shimizu M; Sjöquist PO; Wang QD; Rydén L J Am Soc Nephrol; 1999 Jan; 10 Suppl 11():S137-42. PubMed ID: 9892154 [TBL] [Abstract][Full Text] [Related]
32. Neuroprotective effects of AT1 receptor antagonists after experimental ischemic stroke: what is important? Culman J; Jacob T; Schuster SO; Brolund-Spaether K; Brolund L; Cascorbi I; Zhao Y; Gohlke P Naunyn Schmiedebergs Arch Pharmacol; 2017 Sep; 390(9):949-959. PubMed ID: 28669009 [TBL] [Abstract][Full Text] [Related]
33. Differential effects of losartan and candesartan on vasoconstrictor responses in the rat. Nossaman BD; Baber SR; Nazim MM; Detrolio JD; Kadowitz PJ Can J Physiol Pharmacol; 2007; 85(3-4):360-71. PubMed ID: 17612645 [TBL] [Abstract][Full Text] [Related]
35. Candesartan cilexetil: a review of its preclinical pharmacology. Nishikawa K; Naka T; Chatani F; Yoshimura Y J Hum Hypertens; 1997 Sep; 11 Suppl 2():S9-17. PubMed ID: 9330999 [TBL] [Abstract][Full Text] [Related]
36. Effects of orally applied candesartan cilexetil on central responses to angiotensin II in conscious rats. Gohlke P; Von Kügelgen S; Jürgensen T; Kox T; Rascher W; Culman J; Unger T J Hypertens; 2002 May; 20(5):909-18. PubMed ID: 12011652 [TBL] [Abstract][Full Text] [Related]
37. Effects of candesartan on the renin system in conscious rats. Wagner C; Kurtz A J Am Soc Nephrol; 1999 Jan; 10 Suppl 11():S169-71. PubMed ID: 9892158 [TBL] [Abstract][Full Text] [Related]
38. Renin-angiotensin system and myocardial collagen matrix: modulation of cardiac fibroblast function by angiotensin II type 1 receptor antagonism. Brilla CG; Scheer C; Rupp H J Hypertens Suppl; 1997 Dec; 15(6):S13-9. PubMed ID: 9493122 [TBL] [Abstract][Full Text] [Related]
39. Effects of angiotensin II AT1 receptor inhibition and exercise training on insulin action in rats on high-fat diet. Wang Z; Koike T; Li P; Jiang H; Natsume Y; Mu L; Chen T; Oshida Y Life Sci; 2012 Feb; 90(9-10):322-7. PubMed ID: 22210187 [TBL] [Abstract][Full Text] [Related]
40. Angiotensin AT2 receptor contributes to cardiovascular remodelling of aged rats during chronic AT1 receptor blockade. Jones ES; Black MJ; Widdop RE J Mol Cell Cardiol; 2004 Nov; 37(5):1023-30. PubMed ID: 15522279 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]